Key statistics
As of last trade Tarsus Pharmaceuticals Inc (TARS:NSQ) traded at 46.00, -13.19% below its 52-week high of 52.99, set on Nov 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 46.86 |
---|---|
High | 47.36 |
Low | 45.19 |
Bid | 45.97 |
Offer | 46.08 |
Previous close | 46.58 |
Average volume | 871.04k |
---|---|
Shares outstanding | 38.04m |
Free float | 33.41m |
P/E (TTM) | -- |
Market cap | 1.77bn USD |
EPS (TTM) | -3.76 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 15:55 GMT.
More ▼
- Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
- Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
- Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
- Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer
- Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%
- Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024
- Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference
- Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
- Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
- Tarsus to Participate in Upcoming Investor Conferences
More ▼